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Introduction
Evidence suggests lipid-lowering therapy may improve
exercise performance in patients with peripheral arterial
disease (PAD).
Purpose
We hypothesized that LDL reduction over two years
would improve calf muscle perfusion and metabolism in
PAD as measured by magnetic resonance imaging (CMR)
and spectroscopy (MRS).
Methods
36 patients with mild-to-moderate symptomatic PAD
(mean age 63 ± 11 years, ankle brachial index (ABI) 0.70
± 0.14) were studied for two years after beginning lipid-
lowering therapy. Statin-naïve patients were treated with
simvastatin 40 mg or simvastatin 40 mg plus ezetimibe 10
mg and patients previously on a statin had ezetimbibe 10
mg added (total n = 36). Phosphocreatine recovery time
constant (PCr) was measured using 31P MRS at 1.5 T after
symptom-limited calf muscle exercise. PCr was calculated
using a monoexponential fit of phosphocreatine concen-
tration versus time, beginning at peak exercise. Calf mus-
cle perfusion (n = 28, excluding those with compromised
renal function) was measured at 1.5 T with gadolinium
(0.1 mM/kg) infused after patients used a pedal ergometer
to exhaustion (Figure 1). Slope of the time intensity curve
in the calf muscle region with the greatest signal intensity
defined tissue perfusion and was divided by the arterial
input slope to define perfusion index. Gadolinium
enhanced MRA from the distal aorta to the foot was
graded for location and degree of stenosis (MRA Index).
Skinner-Gardner treadmill test with post-exercise ABI and
6 minute supervised walks were performed. Changes in
parameters over time were compared by ANOVA.
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Left - prior to exerciseFigure 1
Left - prior to exercise. Right - first pass contrast-
enhanced perfusion at peak exercise with increased signal in 
the anterior tibialis and soleusPage 1 of 2
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In the group as a whole, LDL at baseline was 107 ± 34 mg/
dl, decreasing at one year (77 ± 34, p < 0.001) while
remaining stable (74 ± 27, p = ns) at two years. The total
cholesterol at baseline was 178 ± 41 mg/dl, decreased sig-
nificantly at one year (144 ± 38, p < 0.001) and was
unchanged at two years at (142 ± 28, p = ns). Triglycerides
and HDL were unchanged. There was a trend towards
improvement in PCr. There was no significant change in
perfusion index, MRA indices or exercise parameters over
two years (see table 1). No between treatment group dif-
ferences in MRI or MRS parameters were noted.
Conclusion
Lipid-lowering therapy was effective at lowering total and
LDL cholesterol in patients with PAD. Despite this, nei-
ther tissue perfusion nor exercise parameters improved
over 2 years. However, cellular metabolism trended
towards improvement. Therefore, LDL lowering in PAD
may improve calf muscle metabolism, but does not
improve exercise performance or calf muscle perfusion.
Table 1: Changes in MRI, MRS and exercise parameters over time
Baseline One Year Two Years ANOVA p
Perfusion index 0.49 ± 0.18 0.57 ± 0.36 0.55 ± 0.46 0.96
PCr, sec 89.9 ± 64.8 76.4 ± 48.7 69.2 ± 55.0 0.07
MRA Index 0.78 ± 0.64 0.89 ± 0.76 0.89 ± 0.78 0.23
Treadmill exercise time, sec 548 ± 362 590 ± 370 536 ± 360 0.54
6 minute walk distance, ft 1075 ± 406 1176 ± 388 1131 ± 378 0.28
Post-exercise ABI 0.57 0.53 0.56 0.24Page 2 of 2
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